Equity grant to Albemarle (ALB) Chief People Officer adds 1,796 RSUs

Rhea-AI Filing Summary

Gagarinas Autumn M. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corp’s Chief People Officer, Autumn M. Gagarinas, reported an equity award on a Form 4. She received 1,796 shares of common stock in the form of Restricted Stock Units at a stated price of $0.00 per share, bringing her direct holdings to 5,393 shares. The RSUs vest 100% on 03/02/2029, subject to the terms of the award agreement.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gagarinas Autumn M.

Role Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,796	$0.00	--

Holdings After Transaction: Common Stock — 5,393 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gagarinas Autumn M.

(Last) (First) (Middle)

4250 CONGRESS ST.

SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		1,796(1)	A	$0	5,393	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALB’s Autumn M. Gagarinas report on this Form 4?

Autumn M. Gagarinas reported receiving 1,796 shares of Albemarle common stock as a grant of Restricted Stock Units. The award was recorded at a price of $0.00 per share and reflects an equity-based compensation grant, not an open-market purchase or sale.

When do Autumn M. Gagarinas’s new Albemarle (ALB) RSUs vest?

The Restricted Stock Units granted to Autumn M. Gagarinas vest 100% on 03/02/2029. Vesting is subject to the terms of the award agreement, meaning she must meet the specified service or other conditions before the shares fully become hers.

How many Albemarle (ALB) shares does Autumn M. Gagarinas own after this transaction?

Following the reported equity award, Autumn M. Gagarinas directly holds 5,393 shares of Albemarle common stock. This total includes the 1,796 shares associated with the newly granted Restricted Stock Units, as reflected in the Form 4 ownership figures.

Was the Albemarle (ALB) insider transaction a market buy or sell?

The transaction was not a market buy or sell; it was an award acquisition. Autumn M. Gagarinas received 1,796 Restricted Stock Units at $0.00 per share as part of her compensation, rather than purchasing or selling shares on the open market.

What role does Autumn M. Gagarinas hold at Albemarle (ALB)?

Autumn M. Gagarinas serves as Albemarle’s Chief People Officer. The Form 4 shows a compensation-related grant of 1,796 Restricted Stock Units, aligning with her status as a company officer receiving equity as part of total remuneration.